Common Pitfalls That Lead to Late Referrals or Denials in hospice agencies

Accurate hospice eligibility decisions are essential for ensuring patients receive the level of support they need and ensuring organizations remain compliant and financially stable. Yet across the industry, hospice referrals continue to come far too late. Many clinicians hesitate to initiate hospice discussions, and agencies often inherit cases without the documentation or clinical clarity needed to support eligibility. The result is predictable: shortened length of stay, avoidable denials, and families who miss the opportunity for meaningful time with the hospice team.

This blog takes a closer look at the less obvious challenges behind eligibility and how hospice leaders can support earlier, more confident referrals.

What Eligibility Actually Requires

At its core, hospice eligibility still centers around one requirement: a physician certifies that the patient has a life expectancy of six months or less if the illness follows its normal course. CMS also emphasizes that this determination is based on clinical judgment, supported by documentation—not perfect prognostication.

The Local Coverage Determination (LCD) issued by National Government Services outlines two primary pathways to demonstrate eligibility:

1. Non-disease-specific (general) decline, such as:

• Functional deterioration
• Nutritional decline
• Disease progression despite appropriate treatment
• Increased symptom burden
• Recurrent hospitalizations
• Progressive stage 3-4 pressure ulcers in spite of optimal care

2. Disease-specific guidelines, when applicable (renal disease, heart failure, dementia, COPD, neuromuscular conditions, cancer, etc.).

It’s important to remember that patients who stabilize for periods of time do not lose their eligibility outright. Continued certification depends on whether there is still a reasonable expectation of decline. If improvement is sustained, the patient may be discharged and re-enrolled later as their condition changes.

Where Late Referrals Really Come From

1. Prognostic uncertainty from referring providers

Referring clinicians, especially those managing chronic illnesses with unpredictable trajectories, often feel uncomfortable estimating prognosis. Heart failure is a perfect example—patients may “bounce back” after decompensation, making it difficult for providers to recognize when the disease has reached an advanced stage. This uncertainty leads many to wait for unmistakable end-of-life signs before considering hospice, even though CMS doesn’t require that level of certainty.

2. Delayed goals-of-care conversations

Many late referrals happen because the goals of care were not revisited at key decision points. When a patient is considering another line of chemotherapy, escalating device therapy, increased ventilatory support, or can no longer tolerate dialysis, those moments should trigger a structured goals-of-care discussion. Without that intentional pause, referrals occur only after a crisis forces the transition.

3. Misunderstanding disease-specific indicators

Certain misconceptions persist:

• Renal disease: Many think patients must discontinue dialysis before hospice, which is not true—the decision simply affects prognosis.
• Dementia: Some believe eligibility only begins at the very end stages, even though earlier functional decline, weight loss, and recurrent infections may meet criteria.
• COPD and CHF: Clinicians often wait for severe respiratory failure or repeated ICU admissions, despite earlier markers that already support hospice enrollment.

4. Overreliance on hospital triggers

While multiple hospitalizations clearly signal decline, hospice discussions should begin much earlier. Primary care practices, specialty clinics, and SNFs may not have structured screening tools to identify when a patient is approaching eligibility, leading to delays that significantly reduce the length of stay.

Clinical Indicators That Should Prompt Earlier Screening

Across diagnoses, several consistent patterns signal that a patient may be closer to eligibility than providers realize:

• Increasing dependence with ADLs
• Frequent hospitalizations or ER visits
• Reduced oral intake or weight loss
• Progressive weakness, fatigue, or dyspnea
• Cognitive decline or decreased alertness
• Increased time spent sleeping or resting
• Safety concerns or caregiver strain

Disease-specific indicators also matter:

• Dementia: Loss of mobility, communication, or continence; recurrent infections; poor intake
• Heart failure: Persistent symptoms at rest despite optimized therapy
• Renal disease: GFR < 10, hyperkalemia, uremia, or difficulty tolerating dialysis
• COPD: Dyspnea at rest, repeated exacerbations, hypercapnia

When these markers appear, hospice should be part of the conversation—whether or not the patient is “actively dying.”

Documentation Pitfalls That Lead to Denials

The use of modernized hospice software in the role of accurate documentation can play a significant role, as even when a patient clinically meets the criteria, the claim may still be denied if documentation does not clearly demonstrate the decline. Common problems include:

1. Non-specific diagnoses

Terms such as “debility,” “frailty,” or “failure to thrive” cannot be used as primary hospice diagnoses. CMS requires the underlying condition to be identified and supported.

2. Lack of a narrative trajectory

Eligibility must show a pattern of decline over time. Missing notes about ADLs, weight trends, recurrent complications, or worsening symptoms can undermine an otherwise appropriate referral.

3. Insufficient objective measures

Denials often occur when measurable indicators are absent. Key examples include:

• PPS below 40%
• KPS below 50%
• GFR under 10 mL/min
• Dyspnea at rest
• Recurrent infections such as aspiration pneumonia
• Reduced oral intake or significant weight loss

4. Under-documented multi-morbid decline

Many patients qualify based on the cumulative effect of multiple conditions. If documentation does not connect these conditions to functional decline and prognosis, eligibility appears weaker than it actually is.

Prognostic Tools Every Hospice Should Standardize

Using consistent prognostic tools across departments reduces variability and strengthens documentation. The following tools were designed to support both clinical decision-making and eligibility justification:

• Palliative Performance Scale (PPS) – A quick, reliable measure of functional status.
• Palliative Prognostic Index (PPI) – Enhances assessment for short-term prognosis, especially in cancer.
• Palliative Prognostic Score (PaP) – Incorporates lab values when available.
• Karnofsky Performance Scale (KPS) – Widely used in oncology and strongly tied to prognosis.

Standardizing these tools in intake assessments, IDG meetings, and recertifications ensures a common language across the entire organization and provides clearer evidence during audits.

Using Checklists and Structured Workflows to Improve Referral Timing

Hospice agencies that consistently identify eligible patients earlier typically rely on standardized screening tools. These checklists help clinicians communicate decline clearly and provide documentation that aligns with LCD expectations. They also support more consistent decision-making, especially across departments with varying levels of experience.

Integrating these checklists into intake evaluations, IDG reviews, recertification processes, and provider education sessions  can significantly reduce eligibility confusion and prevent missed opportunities for care.

Recommendations for Hospice Leaders

Hospice administrators can meaningfully influence referral timing and compliance by building systems that reduce uncertainty and strengthen documentation. Key strategies include:

• Offering structured eligibility education to referral partners
• Embedding prognostic tools within EMR templates
• Requiring narrative documentation that illustrates a clear decline
• Establishing referral feedback loops with hospitals and SNFs
• Encouraging earlier goals-of-care discussions, especially at treatment decision points
• Conducting routine audits using LCD guidelines
• Monitoring length-of-stay patterns and denial trends through dashboards

Early identification is not just a clinical responsibility—it is an administrative one. When teams have the tools and clarity they need, families benefit from improved continuity, organizations see healthier LOS patterns, and denials decrease.

The Takeaway

Hospice eligibility is broader and more flexible than many referring providers realize. Late referrals often stem from misunderstanding the criteria, waiting for too much “certainty,” or missing key clinical indicators. Administrators play a critical role in closing these gaps by implementing consistent tools, enhancing documentation practices, and educating partners about the actual Medicare requirements.

With the right workflows and clarity, hospice can shift from a last-minute rescue service to a meaningful, months-long support system for patients and families moving through the final stage of life.

References:

1. American College of Cardiology. Palliative Care Consultation and the Transition to Hospice.

2. CMS Local Coverage Determination: LCD L33393 – Hospice – Determining Terminal Status.

3. National Government Services. Coverage Indications, Limitations, and Medical Necessity.

Author’s Note: Views, information, and guidance in this resource are intended for information only. We are not rendering legal, financial, accounting, medical, or other professional advice. Alora disclaims any liability to any third party and cannot make any guarantee related to the content.

Other helpful blogs:

1. What are the key performance indicators for hospice agencies?
2. What are the top strategies to grow your hospice referrals?
3. What are the crucial skills for home health and hospice hiring?
4. Selecting the best caregiver for end-of-life care